Medroxyprogesterone Acetate EP Impurity C

Status: In-stock

It is one of impurity present in Medroxyprogesterone, Medroxyprogesterone acetate inhibits the production of gonadotropin, preventing follicular maturation and ovulation, which is responsible for its ability to prevent pregnancy. This action also thins the endometrium. MPA reduces nuclear estrogen receptors and DNA synthesis in epithelial cells of the endometrium, also induces p53 dependant apoptosis in certain cancer cell lines, and inhibits GABA-A receptors, which reduces nuclear estrogen receptors and DNA synthesis in epithelial cells of the endometrium and induces p53 dependant apoptosis in cancer cell lines, Medroxyprogesterone Acetate used as a contraceptive and in the treatment of secondary amenorrhea, abnormal uterine bleeding.

Request quotation

Additional information on Medroxyprogesterone Acetate EP Impurity C

Catalogue No. VE007806
CAS No. N/A
Molecular Formula C24H34O4
Molecular Weight 386.52 g/mol
Parent drug Medroxyprogesterone
IUPAC Name 6α, 17a-Dimethyl-3, 17-dioxo-D-homoandrost-4-en-17aα-yl acetate
Synonyms N/A
References Sathe, A., & Gerriets, V. (2022, May 19). Medroxyprogesterone. Retrieved November 4, 2022, from Nih.gov website: https://www.ncbi.nlm.nih.gov/books/NBK559192/
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Medroxyprogesterone Acetate EP Impurity C

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden
This field is for validation purposes and should be left unchanged.